Cardiovascular Disease Doctors in Hobart, IN Accepting Medicare

5 Cardiovascular Disease doctors found. Showing 1 - 5

Amy C Bales, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 S Lake Park Ave, Suite 400, Hobart, IN 46342 Phone: 219-942-6166    Fax: 219-942-4106

Dr. Anas Hakam Safadi, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1500 S Lake Park Ave, Hobart, IN 46342 Phone: 219-947-6017    Fax: 219-947-6018

Dr. Jack H Ziegler, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 S Lake Park Ave, Suite 1400, Hobart, IN 46342 Phone: 219-942-6166    Fax: 219-942-4106

Dr. Zlatan Stepanovic, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 S Lake Park Ave, Suite 400, Hobart, IN 46342 Phone: 219-942-6166    Fax: 219-942-4106

Vijay P Shah, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 S Lake Park Ave, 500, Hobart, IN 46342 Phone: 219-942-7463    Fax: 219-756-8001

News Archive

Vaccine and aid workers express anger over CIA plot to collect DNA through fake vaccine program

"Vaccine program workers, who sometimes struggle to gain public trust and governmental cooperation in the first place, are furious about the deception" of the CIA in establishing a fake vaccination program in Pakistan in an attempt to gather DNA from Osama bin Laden's family, ScienceInsider reports.

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

Janssen Therapeutics, Division of Janssen Products, LP, announced today the U.S. Food and Drug Administration has approved OLYSIO (simeprevir), an NS3/4A protease inhibitor, for the treatment of chronic hepatitis C infection as part of an antiviral treatment regimen in combination with pegylated interferon and ribavirin in genotype 1 infected adults with compensated liver disease, including cirrhosis.

Novel gold nanoparticle technology could guide cancer treatment in real-time

A new blood test using gold nanoparticles could soon give oncologists an early and more accurate prognosis of how cancer treatment is progressing and help guide the on-going therapy of patients.

Use of technology that expands access to qualified radiologist leads to earlier diagnosis and treatment of breast cancer

Use of technology that expands access to the most qualified radiologist will lead to earlier diagnosis and treatment of breast cancer, said MedSolutions, a leading provider of medical cost management services.

Read more Medical News

› Verified 7 days ago